Imricor Medical Systems, Inc.

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:51 2024-04-18 am EDT 5-day change 1st Jan Change
0.505 AUD -8.18% Intraday chart for Imricor Medical Systems, Inc. -8.18% -11.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital MT
Mining, Healthcare Stocks Lift Australian Benchmark MT
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7% MT
Amsterdam University Medical Center Resumes Atrial Flutter Procedures with Imricor's NorthStar Mapping System MT
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue MT
Imricor Medical Systems' NorthStar 3D Mapping System Obtains Approval for Use in VISABL-AFL Trial MT
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
Imricor Medical Systems Secures Ethics Approval for Imaging Device Trial; Shares Rise 4% MT
Imricor Medical Systems' VISABL-AFL Trial Obtains Lausanne University Hospital Ethics Approval; Shares Up 8% MT
Imricor's Diagnostic Catheter Granted CE Mark Approval for European Market Sales; Shares Decline 4% MT
Transcript : Imricor Medical Systems, Inc., 2023 Earnings Call, Mar 05, 2024
Imricor Medical Systems' Loss Widens in 2023; Shares Down 8% MT
Imricor Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Imricor Medical Systems Plans Up to AU$15 Million Placement, Entitlement Offer MT
Imricor Medical Systems Secures Approval to Start US Medical Device Trial MT
Imricor Gets Approval from Saudi Food and Drug Authority for ICMR Cardiac Ablation Products MT
Imricor Medical Systems Signs Distribution Agreement with Qatar's East Agency WWL MT
Imricor Medical Systems Signs Deal to Incorporate AI Modules to Heart Mapping System MT
Imricor Medical Raises AU$4.3 Million from Share Placement MT
Imricor Medical Systems Activates New iCMR Site in Croatia MT
Imricor Medical Systems Draws Down Nearly AU$300,000 from AU$30 Million Facility MT
Imricor Medical Systems, Inc. Announces Change of Registered Address in Australia CI
Imricor Medical Systems Secures Germany's Approval for Cardiac Device Trial MT
Imricor Medical Systems Secures $1 Million Grant to Support Development of Catheter Product; Shares Rise 3% MT
Imricor Medical Systems, Inc. Receives USD 1.158 Million Grant CI
Chart Imricor Medical Systems, Inc.
More charts
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3531 USD
Average target price
0.96 USD
Spread / Average Target
+171.91%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMR Stock
  4. News Imricor Medical Systems, Inc.
  5. Imricor Medical : Rises 3% After Adding Ninth Clinical Site in 2020